Manufacturer
23 recalls in our database name Heritage Pharmaceuticals, Inc. as the manufacturing or recalling firm.
Of the 23 recalls from Heritage Pharmaceuticals, Inc. we have scored against our rubric, 2 (9%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 9 (39%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Heritage Pharmaceuticals is recalling Clindamycin Palmitate Hydrochloride oral solution due to the presence of particles and white flakes in reconstituted bottles.
Heritage Pharmaceuticals is recalling 5,882 bottles of Desipramine Hydrochloride Tablets USP 100 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Heritage Pharmaceuticals is recalling 2,418 bottles of Desipramine Hydrochloride Tablets USP 75 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Heritage Pharmaceuticals is recalling 5,880 bottles of Desipramine Hydrochloride Tablets USP 50 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Heritage Pharmaceuticals is recalling 8,754 bottles of Desipramine Hydrochloride Tablets USP 25 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Heritage Pharmaceuticals is recalling 3,750 bottles of Desipramine Hydrochloride Tablets USP 150 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Heritage Pharmaceuticals is recalling 6,979 bottles of Desipramine Hydrochloride Tablets USP 10 mg because N-Nitroso Desipramine exceeded the permissible acceptable daily intake level.
Heritage Pharmaceuticals' desmopressin acetate tablets (0.2mg) have been recalled nationwide due to subpotency. The voluntary recall affects 13,805 bottles; no illnesses have been reported.
Heritage Pharmaceuticals is recalling 408 bottles of Acyclovir 400 mg tablets distributed in Ohio due to incorrect or missing lot and expiration dates.
Heritage Pharmaceuticals is recalling specific bottles of Felodipine Extended Release Tablets because routine testing found out-of-specification impurities.
Heritage Pharmaceuticals is recalling Amikacin Sulfate Injection vials because microbial growth was detected in a sub-lot. The affected product is distributed nationwide in the USA.
Heritage Pharmaceuticals is recalling Prochlorperazine Edisylate Injection because microbial growth was detected in a sublot. The affected vials are distributed nationwide.
Heritage Pharmaceuticals is recalling Losartan Potassium Tablets 100 mg because FDA labs found an impurity above acceptable levels.
Heritage Pharmaceuticals is recalling Losartan Potassium Tablets 100 mg because FDA labs found an impurity above acceptable levels.
Heritage Pharmaceuticals is recalling Losartan Potassium Tablets 50 mg because FDA labs found an impurity above acceptable levels.
Heritage Pharmaceuticals is recalling Losartan Potassium Tablets 25 mg because FDA labs found an impurity above acceptable levels.
Heritage Pharmaceuticals is recalling Losartan Potassium Tablets 50 mg because FDA testing found an impurity above acceptable levels.
Heritage Pharmaceuticals is recalling 11,888 vials of Etomidate Injection because the drug was found to be subpotent. The recall is voluntary and nationwide.
Heritage Pharmaceuticals is recalling Cidofovir Injection vials due to complaints about dried powder on the outside of the bottles, which raises concerns about sterility.
Heritage Pharmaceuticals is recalling Cidofovir Dihydrate Injection due to complaints of dried powder on the outside of the bottle, which raises concerns about the product's sterility.
Heritage Pharmaceuticals is recalling specific lots of Gliptizide and Metformin HCL tablets because they failed impurity specifications. The affected bottles were distributed nationwide.
Heritage Pharmaceuticals is recalling RIFAMPIN for Injection, USP, 600 mg per vial, due to quality control concerns regarding the assurance of sterility.
Heritage Pharmaceuticals is recalling Colistimethate Sodium Injection due to quality control concerns regarding sterility assurance.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Heritage Pharmaceuticals
pharmaceuticals manufacturer in New Jersey
Source: Wikidata (Q28207120), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.